- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
A Bipartisan Fireside Chat: What the Congress and New Administration May Mean for Access to Treatment
A discussion with Jeanne Ireland, advisory board member, District Policy Group and former senior advisor to the Commissioner and Associate Commissioner for Legislation at the FDA, Obama Administration; and The Honorable Dr Phil Gingrey, senior advisor, Drinker Biddle & Reath and District Policy Group and former US Congressman, R-Georgia, 2003-2015. This discussion took place at the Cost-Sharing Roundtable: Sustainable Strategies for Providing Access to Critical Medications. The event was co-hosted by the PAN Foundation and The American Journal of Managed Care®.
A discussion with Jeanne Ireland, advisory board member, District Policy Group and former senior advisor to the Commissioner and Associate Commissioner for Legislation at the FDA, Obama Administration; and The Honorable Dr. Phil Gingrey, senior advisor, Drinker Biddle & Reath and District Policy Group and former US Congressman (R-GA), 2003-2015. This discussion took place at the Cost-Sharing Roundtable: Sustainable Strategies for Providing Access to Critical Medications. The event was co-hosted by the PAN Foundation and The American Journal of Managed Care®.
Long-Term Lebrikizumab Provides Sustained Skin Clearance in Atopic Dermatitis
August 5th 2025In this subanalysis of data from the ADjoin trial of lebrikizumab, the interleukin-13 receptor inhibitor that is also a monoclonal antibody showed itself to be effective over the long term in patients with atopic dermatitis on maintenance therapy.
Read More
